BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8344866)

  • 1. Synthesis and antiviral activity of adenosine deaminase-resistant oxetanocin A derivatives: 2-halogeno-oxetanocin A.
    Masuda A; Kitagawa M; Tanaka A; Saito S; Shimada N; Ikeda R; Hoshino H; Daikoku T; Nishiyama Y
    J Antibiot (Tokyo); 1993 Jun; 46(6):1034-7. PubMed ID: 8344866
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of L-oxetanocin.
    Gumina G; Chu CK
    Org Lett; 2002 Apr; 4(7):1147-9. PubMed ID: 11922804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ring-enlarged oxetanocin A analogue as an inhibitor of HIV infectivity.
    Tseng CK; Marquez VE; Milne GW; Wysocki RJ; Mitsuya H; Shirasaki T; Driscoll JS
    J Med Chem; 1991 Jan; 34(1):343-9. PubMed ID: 1992135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activities of carbocyclic oxetanocin analogues.
    Maruyama T; Sato Y; Horii T; Shiota H; Nitta K; Shirasaka T; Mitsuya H; Honjo M
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2719-25. PubMed ID: 1963811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiviral activities of 9-cyclopentylpurine derivatives.
    Kojima E; Ohta K; Miyawaki S; Date T; Machida M; Murakami K
    Nucleic Acids Symp Ser; 1995; (34):107-8. PubMed ID: 8841575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activity of 3'-fluorocarbocyclic oxetanocin A.
    Sato Y; Maruyama T
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):91-5. PubMed ID: 7895312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of (Z)- and (E)-9-[(2-hydroxyethylidene)cyclopropyl]adenine--new methylenecyclopropane analogues of adenosine and their substrate activity for adenosine deaminase.
    Qui YL; Ksebati MB; Zemlicka J
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):31-7. PubMed ID: 10772701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of carbocyclic oxetanocin analogs bearing fluorine and their antiviral activities.
    Sato ; Maruyama T
    Nucleic Acids Symp Ser; 1995; (34):159-60. PubMed ID: 8841601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (R)-(-)- and (S)-(+)-adenallene: synthesis, absolute configuration, enantioselectivity of antiretroviral effect, and enzymic deamination.
    Megati S; Goren Z; Silverton JV; Orlina J; Nishimura H; Shirasaki T; Mitsuya H; Zemlicka J
    J Med Chem; 1992 Oct; 35(22):4098-104. PubMed ID: 1304169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbocyclic oxetanocins lacking the C-3' methylene.
    Wu J; Schneller SW; Seley KL
    J Med Chem; 1997 Apr; 40(9):1401-6. PubMed ID: 9135038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halogenated isoniazid derivatives as possible antimycobacterial and anti-HIV agents--III.
    Vigorita MG; Ottanà R; Zappalà C; Maccari R; Pizzimenti FC; Gabbrielli G
    Farmaco; 1994 Dec; 49(12):775-81. PubMed ID: 7893334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-HIV activity of 9-[c-4,t-5-bis(hydroxymethyl)cyclopent-2-en-r-1-yl]-9H-adenine.
    Katagiri N; Nomura M; Sato H; Kaneko C; Yusa K; Tsuruo T
    J Med Chem; 1992 May; 35(10):1882-6. PubMed ID: 1588565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.
    Maruyama T; Hanai Y; Sato Y; Snoeck R; Andrei G; Hosoya M; Balzarini J; De Clercq E
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):516-21. PubMed ID: 8386594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines.
    Baszczyňski O; Jansa P; Dračínský M; Klepetářová B; Holý A; Votruba I; de Clercq E; Balzarini J; Janeba Z
    Bioorg Med Chem; 2011 Apr; 19(7):2114-24. PubMed ID: 21429755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
    J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A convenient approach to the synthesis of nucleic acid bases allenic derivatives, possessing anti-HIV activity.
    Kochetkova MV; Tsytovich AV; Mitsner BI
    Nucleic Acids Symp Ser; 1991; (24):233. PubMed ID: 1841305
    [No Abstract]   [Full Text] [Related]  

  • 17. Ring-expanded analogues of natural oxetanocin: (+) and (-) hydroxymethyl isodideoxyadenosine.
    Chun BK; Vadakkan JJ; Nair V
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):725-8. PubMed ID: 16248024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
    J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclic Puromycin Analogs: 9-[(2-phenylalanylamidoethoxy) methyl] adenine and 9-(3-phenylalanylamidopropyl) adenine.
    Kelley JL; Miller CA; Schaeffer HJ
    J Pharm Sci; 1981 Oct; 70(10):1169-71. PubMed ID: 7028948
    [No Abstract]   [Full Text] [Related]  

  • 20. Highly stereoselective synthesis of carbocyclic oxetanocin and its related compounds from bicycloamides.
    Katagiri N; Nomura M; Sato H; Kaneko C
    Nucleic Acids Symp Ser; 1990; (22):129-30. PubMed ID: 2101895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.